Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000558414 | SCV000643691 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000614147 | SCV000711406 | likely benign | not specified | 2017-06-01 | criteria provided, single submitter | clinical testing | p.Val23050Val in exon 275 of TTN: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 7/34164 Latino c hromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstit ute.org/; dbSNP rs192902075). |
CHEO Genetics Diagnostic Laboratory, |
RCV001171264 | SCV001333973 | benign | Cardiomyopathy | 2017-11-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840672 | SCV002100172 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840673 | SCV002100173 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840674 | SCV002100174 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840671 | SCV002100175 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341355 | SCV002642135 | likely benign | Cardiovascular phenotype | 2019-07-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001796108 | SCV004150277 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Diagnostic Laboratory, |
RCV001796108 | SCV002035048 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001796108 | SCV002037729 | likely benign | not provided | no assertion criteria provided | clinical testing |